This site is intended for health professionals only

Current and novel therapies in lupus management


Rizgar A Mageed, B Pharm, PhD, FRCPath

Professor of Experimental Immunology, William Harvey Research Institute, 

Article continues below this sponsored advert
Cogora InRead Image
Explore the latest advances in respiratory care at events delivered by renowned experts from CofE

Queen Mary University of London, UK


Systemic lupus erythematosus (SLE) is an autoimmune disease of unknown etiology. The disease is associated with heterogeneous manifestations and with episodes of disease flare and remission. The cause of SLE remains unknown but a number of factors are known to promote susceptibility to the disease. These include genetic, environmental and hormonal factors. The involvement of genetic factors is indicated by increased concordance rate of SLE in monozygotic twins (24

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine